Dominican company based in Santo Domingo · We only ship within the Dominican Republic · No international shippingDominican Republic only · No international shipping
ES Home Catalog Education COAs Calculator Founder
KPV
Renova Verification
  • ✓≥99% purity by HPLC + mass spectrometry
  • ✓Independent Janoshik 3rd-party analysis
  • ✓−20°C lyophilized · 2–8°C reconstituted
🧪 View COA →
Home › Products › Immune › KPV
← Back to catalog ImmuneAvailable

KPV (10 mg)

Anti-inflammatoryIBDα-MSH
$90 USD10 mg/vial
🧪 Bacteriostatic water — needed to reconstitute the lyophilized vial
💰 Buy by volume
3+ of one
Save 15%
5+ of one
Save 25%
★ Wholesale
10+ of one
Save 40%
🔀 Mix & Match · across different products: 3+ items 10% · 5+ 15% · 7+ 20%
The best discount per product is applied automatically at checkout (they don't stack). Excludes bacteriostatic water; Retatrutide and Tirzepatide only get same-product volume. Can't be combined with promo codes.
🧪 COA❄️ Cold chain🛡️ Replacement guarantee🔒 Secure payment📦 Nationwide shipping🇺🇸 cGMP · ISO 9001 guidelines · COA

C-terminal fragment of α-MSH (Lys-Pro-Val) — potent anti-inflammatory with special affinity for intestinal and skin mucosa.

  • Mechanism: C-terminal fragment of α-MSH (Lys-Pro-Val); anti-inflammatory action.
  • Evidence: Mostly preclinical; models of gut and skin inflammation.
  • In context: Limited human clinical data.
Research range · SC
200–500 mcg per application · 1–2×/day
🟡 Preclinical · no human trials

Ranges cited in research literature. Not a usage recommendation. For research use only.

📋 Technical datasheet · Compound specifications
CompoundKPV
Origin🇺🇸 From US-based suppliers that follow strict cGMP & ISO 9001 guidelines
FormLyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formulaC16H30N4O4
Molecular weight342.4 g/mol
SequenceLys-Pro-Val
Purity≥99% by HPLC + mass spectrometry (Janoshik Analytical)
StorageLyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C · stability varies by peptide (see the reconstitution guide and the product COA)
Recommended solventBacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain2–8°C in transit · controlled thermal packaging
UseResearch Use Only (RUO). Not intended for human or veterinary use.

Typical values for this compound category. For product-specific data, see the corresponding COA at /en/coa/.

This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.

KPV: research profile

KPV is a tripeptide — lysine, proline, valine — matching the last three amino acids (11-13) of α-melanocyte-stimulating hormone (α-MSH). The full thirteen-amino-acid α-MSH has two faces: a pigmentary one, mediated by melanocortin receptors, and an anti-inflammatory one. The KPV fragment keeps the second and loses the first, which made it a tool for studying inflammation without interfering with melanogenesis.

Its mechanism is peculiar in that it needs no melanocortin receptor. In intestinal epithelial cells and keratinocytes it enters through the oligopeptide transporter PepT1, accumulates in the cytoplasm and inhibits the nuclear translocation of NF-κB, with the ensuing drop in IL-6, IL-8, TNF-α and other cytokines. In murine colitis models (DSS and TNBS) it reduced inflammation and histological damage, and in allergic contact dermatitis models it dampened the cutaneous inflammatory response.

All evidence is preclinical: cell cultures and rodents, with the reference study by Dalmasso and colleagues in Gastroenterology (2008). There are no published human clinical trials and no regulatory status as a drug. Because of its minimal size it is highly soluble and relatively stable, although like any reconstituted peptide it must be kept cold. Renova distributes it for research only, individually and as a component of the KLOW blend.

KPV technical data

ClassTripeptide, C-terminal fragment of α-MSH (residues 11-13)
SequenceLys-Pro-Val (3 aa)
CAS67727-97-3
MechanismPepT1 uptake → NF-κB inhibition; no activity at melanocortin receptors
Models studiedMurine colitis (DSS, TNBS); contact dermatitis; keratinocytes and Caco-2 epithelium
StatusPreclinical; no human trials, no approval
PropertiesHighly water-soluble; no associated pigmentation; no cysteine or methionine (low oxidation sensitivity)
Renova presentationsIndividual 10 mg vial; component of the KLOW blend

Questions about KPV

Does KPV darken the skin like α-MSH or Melanotan?

No. The pigmentary action of α-MSH depends on melanocortin receptors, and KPV does not activate them; it keeps only the hormone's anti-inflammatory region. That is precisely why it was isolated as a fragment: to study inflammation with no effect on melanogenesis.

In which models has KPV been studied?

Mainly in induced colitis in mice (DSS and TNBS) and in skin inflammation, plus cultures of intestinal epithelial cells and keratinocytes. The reference work is Dalmasso et al. in Gastroenterology (2008). There are no human clinical trials.

How does KPV get into the cell?

Through PepT1, the di- and tripeptide transporter the gut uses to absorb protein-digestion products. It is highly expressed in the intestinal epithelium, which explains why KPV's effect is most evident in the colonic mucosa.

What is the difference between buying KPV alone and in the KLOW blend?

The individual vial contains 10 mg of KPV and allows studying it in isolation or at whatever ratio is decided. In KLOW it comes fixed alongside BPC-157, GHK-Cu and TB-500 in one vial. Our KPV guide and the GLOW vs KLOW guide explain the contexts for each option.

Related reading: KPV: Anti-inflammatory Tripeptide for Skin & Mucosa · KLOW: The Repair Blend with KPV · HHS and peptide compounding in the U.S.: the October 2026 policy and its 10 conditions

Informational content based on published scientific literature; it is not a recommendation for use or medical advice. Product strictly for research use (RUO), not suitable for human or veterinary consumption.

Questions? Write us

Your Order

Your cart is empty